Assertion: penumbra | /r/HasProperty | pen
Facets:
Source sentences:
text: Shares of Penumbra (PEN) are down 5% in early trading after short-selling focused research firm Spruce Point issued a short report on the stock, outlining their thesis why the share price is at risk for 40%-55% downside risk.
text: Penumbra (PEN) is a $5 billion medical technology company specializing in minimally-invasive instruments for neurovascular and peripheral vascular diseases.
text: Penumbra (PEN) is the IBD Stock Of The Day, a provider of medical devices with a broad product portfolio showing an offbeat cup-with-handle stock pattern.
text: Penumbra (PEN) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of $0.18 per share.
text: -- Penumbra, Inc.(NYSE: PEN) today announced that the format for its 2020 Annual Meeting of Stockholders (the "Annual Meeting") has been changed from an in-person meeting to a virtual-only meeting at the previously announced date and time of June 3, 2020 at 11:00 a.m. Pacific Time due to the public health concerns related to the COVID-19 pandemic and to support the health and safety of its stockholders, employees and other meeting participants.
text: Penumbra (PEN) came out with quarterly earnings of $0.25 per share, beating the Zacks Consensus Estimate of $0.18 per share.
text: SEATTLE, March 9, 2020 /PRNewswire/ -- HTC VIVE®, the leader in premium virtual reality (VR), and Penumbra (NYSE: PEN), a global healthcare company focused on innovative therapies, announced today that Penumbra's new solution for stroke recovery, the REAL™
text: Penumbra (PEN), based in Alameda, Ca., provides health services focused on interventional therapies; technically, the stock has broken out from a 10-week, double bottom base, notes Leo Fasciocco, editor of Ticker Tape Digest.